TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03550534 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03434769 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00792363 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04729543 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT03836482 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02000713 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00062101 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01221831 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT05886231 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04474431 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04474431 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05975489 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT05975489 — Predictive Biomarker (PRD); Safety Biomarker (SAF): GSTP1
Genes: GSTP
Study NCT02371421 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04201470 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT04201470 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT00455962 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02705911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04438850 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00317434 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT00045266 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02999984 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02999984 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT02999984 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT02285634 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03572842 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01977794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02092883 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01129739 — Predictive Biomarker (PRD): RARS1 mRNA
Genes: RARS1; RARS
Study NCT01129739 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03207958 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT02814526 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00338780 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00583518 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02771756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01357772 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT01357772 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT02650375 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01359748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03245749 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT01449682 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04224896 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT00618033 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03105934 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01253317 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT01253317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04155593 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01367717 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03056079 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01270490 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00171340 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00900016 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02370498 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04497272 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03186755 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00499317 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01876043 — Predictive Biomarker (PRD): MAP3K5 mRNA
Genes: MAP3K5; ASK1; MAPKKK5; MEKK5
Study NCT01876043 — Predictive Biomarker (PRD): JUN mRNA
Genes: JUN
Study NCT00079937 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01856387 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT01757899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01757899 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01757899 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01757899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01757899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02409186 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02409186 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01729988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00285519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03082300 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03082300 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00617409 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04082936 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00783575 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study NCT00746902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00984178 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00984178 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01317940 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00797862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02358187 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT02538640 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study NCT01593501 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02815176 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT01912976 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT00736866 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01260376 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02201459 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02201459 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03101982 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03101982 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03101982 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02249221 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT00179868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02893358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00809237 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00809237 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02556892 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT00697216 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00699478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00646841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04675749 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT03547856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04093128 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02283190 — Surrogate Endpoint (SUR): Serum asparaginase
Study NCT02090296 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT02352857 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT00958802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03454932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03384433 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01295086 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00186823 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01918579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00384293 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04315441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03991871 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02275936 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00017641 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02524184 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT00279084 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00279084 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00356018 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00234143 — Predictive Biomarker (PRD): RARS1 mRNA
Genes: RARS1; RARS
Study NCT04540055 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03240393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02958397 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03988517 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT04415502 — Predictive Biomarker (PRD): CTHRC1 mRNA
Genes: CTHRC1; UNQ762/PRO1550
Study NCT02841696 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT00677417 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00677417 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01522950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03418792 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT02419235 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01403662 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04491357 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04008693 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04008693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01572519 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT02669875 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06616545 — Predictive Biomarker (PRD): AGL mRNA
Genes: AGL; GDE
Study NCT02891369 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02891369 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06617117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01841840 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02104440 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02651558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04488653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04509986 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00822341 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT00562575 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT01592916 — Predictive Biomarker (PRD): IGF1 mRNA
Genes: IGF1; IBP1
Study NCT01592916 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03779152 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study NCT02266394 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01273415 — Predictive Biomarker (PRD): CCNB1 mRNA
Genes: CCNB1; CCNB
Study NCT01273415 — Predictive Biomarker (PRD): Proliferation marker protein Ki-67
Genes: MKI67
Study NCT01273415 — Predictive Biomarker (PRD): MYBL2 mRNA
Genes: MYBL2; BMYB
Study NCT01273415 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04326257 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT04326257 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00000948 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000948 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06360861 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00075244 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT00678821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01468896 — Safety Biomarker (SAF): Interleukin 12
Study NCT04603755 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02177500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05487716 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01904734 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00001527 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study NCT00001527 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02321540 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02321540 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02797483 — Safety Biomarker (SAF): Glycerol backbone
Study NCT01012193 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01252368 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01252368 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03208803 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT03208803 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT00191464 — Predictive Biomarker (PRD): NPL mRNA
Genes: NPL; C1orf13
Study NCT01259687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00775606 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03095352 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03095352 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03095352 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01829802 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT03069677 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01688544 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00374075 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00374075 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00036647 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00036647 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04558333 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT02327793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02380079 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01988324 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01988324 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00401999 — Safety Biomarker (SAF): OPRM1
Genes: MOR1; MOP
Study NCT04615936 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00346866 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02881086 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT02881086 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00298740 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT01526460 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01445418 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01445418 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00111956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00111956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04213872 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04213872 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT00943267 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT03937687 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03865420 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04222387 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT00810303 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00810303 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00810303 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP
Study NCT00810303 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03381430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03583437 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00071084 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00977548 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00977548 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02907099 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03146637 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT03146637 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03146637 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT03180190 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study NCT04077684 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01647711 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02310789 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00506506 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00506506 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT05008016 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04569786 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01891812 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04616443 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01103128 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01103128 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00746005 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02605213 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT01694420 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01694420 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01880788 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01755195 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01755195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01755195 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01755195 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00333476 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03670381 — Predictive Biomarker (PRD): HDAC4 mRNA
Genes: HDAC4; KIAA0288
Study NCT04344457 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02000531 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04149080 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04149080 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00622765 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04377997 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04651738 — Predictive Biomarker (PRD): BHLHE22 mRNA
Genes: BHLHE22; BHLHB5; TNRC20
Study NCT04651738 — Predictive Biomarker (PRD): CELF4 mRNA
Genes: CELF4; BRUNOL4
Study NCT04651738 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HAND2 mRNA
Genes: HAND2; BHLHA26; DHAND
Study NCT04651738 — Predictive Biomarker (PRD): ZNF177 mRNA
Genes: ZNF177
Study NCT04651738 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04701502 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00721864 — Pharmacodynamic Biomarker (PDY): Major prion protein
Genes: PRNP; ALTPRP; PRIP; PRP
Study NCT00509496 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04052698 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00169299 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00003819 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT02055586 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT01518751 — Surrogate Endpoint (SUR): Blood pressure